Welcome to LookChem.com Sign In|Join Free
  • or
2-hydroxy-5-(trifluoromethyl)benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

933982-96-8

Post Buying Request

933982-96-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

933982-96-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 933982-96-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,9,8 and 2 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 933982-96:
(8*9)+(7*3)+(6*3)+(5*9)+(4*8)+(3*2)+(2*9)+(1*6)=218
218 % 10 = 8
So 933982-96-8 is a valid CAS Registry Number.

933982-96-8Relevant academic research and scientific papers

Color Tuning of Efficient Electroluminescence in the Blue and Green Regions Using Heteroleptic Iridium Complexes with 2-Phenoxyoxazole Ancillary Ligands

Benjamin, Helen,Liang, Jie,Liu, Yu,Geng, Yun,Liu, Xingman,Zhu, Dongxia,Batsanov, Andrei S.,Bryce, Martin R.

, p. 1810 - 1821 (2017/05/15)

A rational molecular design strategy for tuning the emission color of phosphorescent complexes by functionalization of the bis(2-phenylpyridine)(2-(2′-oxyphenyl)-2-oxazoline/oxazole)iridium(III) framework is reported. Five new complexes (2-6) have been synthesized in good yields and characterized by cyclic voltammetry, absorption, and photoluminescence studies, by time-dependent density functional theory (TD-DFT) calculations, and by single-crystal X-ray diffraction studies for complexes 2, 4, and 6. An interesting feature of the complexes is that the HOMO is localized on the Ir d-orbitals and the phenoxylate part of the “ancillary” ligand, while the LUMO is located on the pyridyl ring of the ppy ligands. A few other complexes containing 2′-oxyphenyl-2-oxazoline/oxazole ancillary ligands have been reported previously; however, until now there has not been a systematic investigation into manipulating this unusual frontier orbital distribution to tune the emissive properties. It is shown that exchanging the phenylpyridine (ppy) ligand for 2,4-difluoro-ppy gives a blue shift of 21-22 nm (from 1 to 2 and from 4 to 5), and the introduction of electron-withdrawing substituents (SO2Me, CF3) onto the phenoxylate ring of the (2′-oxyphenyl)-2-oxazole ligand results in a further blue shift of 13-20 nm. Combining these functionalizations gives sky-blue emission with λmaxPL 476 and 479 nm for complexes 5 and 6 in dichloromethane solution. The solution quantum yields of all the complexes are within the range ΦPL 0.42-0.73. The observed lifetimes (τobs = 1.52-3.01 μs) and spectral profiles are indicative of phosphorescence from a mixture of ligand-centered and MLCT excited states. (TD-)DFT calculations are in close agreement with the observed photophysical and electrochemical properties of the complexes. Phosphorescent organic light-emitting diodes have been fabricated using complexes 2, 3, 5, and 6 as the emitter, doped in a 4,4′-bis(N-carbazolyl)biphenyl host, giving efficient emission in the blue-green region. Notably, complex 5 gives λmaxEL 480 nm with a maximum brightness of 26150 cd m-2.

Synthesis and biological activity of novel 1,3-benzoxazine derivatives as K+ channel openers

Yamamoto, Satoshi,Hashiguchi, Shohei,Miki, Shokyo,Igata, Yumiko,Watanabe, Toshifumi,Shiraishi, Mitsuru

, p. 734 - 745 (2007/10/03)

A new series of 1,3-benzoxazine derivatives with a 2-pyridine 1-oxide group at C4 was designed to explore novel K+ channel openers. Synthesis was carried out by using a palladium(0)-catalyzed carbon-carbon bond formation reaction of imino-triflates with organozinc reagents and via a new one-pot 1,3-benzoxazine skeleton formation reaction of benzoylpyridines. The compounds were tested for vasorelaxant activity in tetraethylammonium chloride (TEA) and BaCl2-induced and high KCl-induced contraction of rat aorta to identify potential K+ channel openers, and also for oral hypotensive effects in spontaneously hypertensive rats. An electron- withdrawing group with the proper shape at C6 and a methyl or halogens group at C7 of the 1,3-benzoxazine nucleus were required for the development of optimal vasorelaxant and hypotensive activity. In particular, 2-(6-bromo-7- chloro-2,2-dimethyl-2H-1,3-benzoxazin-4-yl)pyridine 1-oxide (71) showed more potent vasorelaxant activity (EC50=0.14 μM) against TEA and BaCL2- induced contraction and longer-lasting hypotensive effects than cromakalim (1).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 933982-96-8